Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Myectomy

Subvalvular myectomy has a reported success of more than 90% with a mortality rate of less than 2%, but this therapy is not applicable to every patient. Transcatheter ablation of septal hypertrophy has been performed since 1994 as a reasonable option for obstructive HCM patients. An increasing number of reports claim efficacy comparable to that of the surgical approach (3). [Pg.593]

Surgical myectomy involves incision into and resection of small portions of the hypertrophied septum resulting in a significant reduction or abolition of intramyocardial gradients and reduction in mitral incompetence. Patients report a significant reduction in disabling symptoms and improvement in exercise capacity, and the benefit is usually sustained, The complications are few and the postoperative mortality is... [Pg.603]

Patients who have not obtained a satisfactory result after surgical myectomy may also be candidates for septal ablation. Selected patients with advanced function class II with obstructive symptoms that interfere with their occupation may also be candidates for intervention. [Pg.604]

TSable 2 Summary of studies comparing surgical myectomy and septal ablation... [Pg.608]

Table 4 Reported complication after surgical myectomy or septal ablation... Table 4 Reported complication after surgical myectomy or septal ablation...
Septal ablation related mortality at experienced centers is currently 1% to 2%, similar to that of surgical myectomy (Table 4). Conduction system abnormalities are relatively common complications of septal ablation, Permanent right bundle branch block occurs in about 50% of patients and transitory complete heart block in 60% and permanent pacemakers required for high grade atrioventricular block in about 5% to 20%, Concerns of late occurrence of complete heart block following septal ablation mandates in-patient monitoring for 4 to 5 days,... [Pg.611]

Ommen SR, Maron BJ, Olivotto I, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005 46 470-476. [Pg.611]

Nagueh Sp Ommen SR, Lakkis NM, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 2001 38 1701 -1706. [Pg.611]

I I Qin JX, Shiota T Lever HM, et al. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 2001 38 1994-2000. [Pg.611]

Firoozi S, Elliott PM, Sharma S, et al. Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J 2002 23 1617-1624. [Pg.611]

Talreja DR, Nishimura RA, Edwards WD, et al. Alcohol septal ablation versus surgical septal myectomy comparison of effects on atrioventricular conduction tissue, J Am Coll Cardiol 2004 44 2329-2332. [Pg.612]

Ablation of the myocardium using alcohol is another alternative to surgery. Septal ablation with alcohol results in the same type of outcomes as seen with myectomy. Long-term follow-up is limited because this procedure has been used for less than a decade. Since it is a percutaneous procedure (similar to cardiac catheterizations), it is being done more frequently than myectomy. There is some concern that the risk for arrhythmia-related cardiac events may increase following alcohol ablation. Long-term follow-up is needed to assess this risk. Complete heart block is a common complication of septal... [Pg.368]

For patients with a significant obstruction to LV outflow who do not respond to medical management, a surgical approach may be necessary. Septal myectomy and alcohol ablation have been employed. These approaches generally are reserved for patients who have an outflow gradient of more than 50 mm Hg and/or severe symptoms and who have failed an adequate trial of medical therapy. [Pg.370]

A meta-analysis to compare the efficacy of posterior internal anal sphincter (IAS) myectomy with intrasphinc-teric botulinum toxin injection for treatmenf of IAS achalasia involving 16 prospective and retrospective studies in a total of 395 patienfs [18 ] demonstrated no significant difference in continued use of laxatives or rectal... [Pg.174]


See other pages where Myectomy is mentioned: [Pg.604]    [Pg.604]    [Pg.605]    [Pg.607]    [Pg.607]    [Pg.608]    [Pg.608]    [Pg.608]    [Pg.608]    [Pg.610]    [Pg.610]    [Pg.610]    [Pg.610]    [Pg.610]    [Pg.213]    [Pg.380]    [Pg.408]    [Pg.2458]    [Pg.368]    [Pg.116]   


SEARCH



Myectomy complications

Myectomy surgical

© 2024 chempedia.info